Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07148232 · ClinicalTrials.gov registry record · Phase 4
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
A Phase 4 study of Tobacco Use and Tobacco Use Cessation, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07148232: Recruiting Phase 4 study of Tobacco Use and Tobacco Use Cessation, sponsored by University of California, San Francisco.
NCT07148232 is a Phase 4 study of Tobacco Use and Tobacco Use Cessation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 150 participants, below the 377-participant average among 76 other Tobacco Use trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07148232, a Phase 4 study of Tobacco Use and Tobacco Use Cessation, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
Primary Outcome
The percentage of participants who attended at least 75% or 7 of the 14 coaching sessions will be reported.
Conditions Studied
Interventions
- DRUG Nicotine Replacement Therapy (NRT)
- BEHAVIORAL Wellness Coaching
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 4 |
What NCT07148232 shows while recruiting
NCT07148232 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 377-participant average among 76 other Tobacco Use trials with a reported enrollment target (60% lower).
The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Nicotine Replacement Therapy (NRT) is the first listed.
NCT07148232 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07148232 about?
NCT07148232 is a clinical study titled "Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness". This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
What is the current status of trial NCT07148232?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2025-11-14. Estimated completion is 2027-06-30.
What conditions does trial NCT07148232 study?
This clinical trial studies the following conditions: Tobacco Use, Tobacco Use Cessation, Tobacco Dependence, Tobacco Cessation, Tobacco Abstinence.
What interventions are being tested in trial NCT07148232?
The interventions under investigation include: Nicotine Replacement Therapy (NRT) (DRUG), Wellness Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT07148232?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07148232 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07148232's enrollment target sits among peer trials
150 31st of 76 higher than 45 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Semaglutide on Tobacco Use and Related Health Behaviors
RECRUITING · Phase 4
-
Minocycline and Tobacco Craving in Smokers With Schizophrenia
COMPLETED · Phase 4
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
RECRUITING · Phase 2
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI